A
Alastair Mander
Researcher at Barwon Health
Publications - 7
Citations - 617
Alastair Mander is an academic researcher from Barwon Health. The author has contributed to research in topics: Vitamin B12 & Diabetes mellitus. The author has an hindex of 4, co-authored 7 publications receiving 487 citations. Previous affiliations of Alastair Mander include Geelong Hospital.
Papers
More filters
Journal ArticleDOI
Increased risk of cognitive impairment in patients with diabetes is associated with metformin
Eileen M. Moore,Eileen M. Moore,Alastair Mander,David Ames,Mark A. Kotowicz,Mark A. Kotowicz,Mark A. Kotowicz,Ross Carne,Ross Carne,Henry Brodaty,Michael Woodward,Karen Boundy,Kathryn A. Ellis,Ashley I. Bush,Noel G. Faux,Ralph N. Martins,Ralph N. Martins,Cassandra Szoeke,Christopher C. Rowe,David A. K. Watters,David A. K. Watters +20 more
TL;DR: Vitamin B12 and calcium supplements may alleviate metformin-induced vitamin B12 deficiency and were associated with better cognitive outcomes in older people with diabetes who are taking met formin.
Journal ArticleDOI
Cognitive impairment and vitamin B12: a review.
TL;DR: Low serum vitamin B12 levels are associated with neurodegenerative disease and cognitive impairment, and there is a need for large, well-resourced clinical trials to close the gaps in current understanding of the nature of the associations of vitamin B 12 insufficiency and neurodegnerative disease.
Journal ArticleDOI
Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: Combined data from three cohorts
Eileen M. Moore,David Ames,Alastair Mander,Ross Carne,Henry Brodaty,Michael Woodward,Karyn Boundy,Kathryn A. Ellis,Ashley I. Bush,Noel G. Faux,Ralph N. Martins,Colin L. Masters,Christopher C. Rowe,Cassandra Szoeke,David A. K. Watters +14 more
TL;DR: High folate or folic acid supplements may be detrimental to cognition in older people with low vitamin B12 levels, and prospective studies should be a high priority.
Journal ArticleDOI
Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013;36:2981–2987
Eileen M. Moore,Alastair Mander,David Ames,Mark A. Kotowicz,Ross Carne,Henry Brodaty,Mark Woodward,Karyn Boundy,Kathryn A. Ellis,Ashley I. Bush,Noel G. Faux,Ralph N. Martins,Cassandra Szoeke,Christopher Rowe,David A. K. Watters +14 more
TL;DR: Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Boundy K, Ellis KA, Bush AI, Faux NG, Martins R, Szoeke C, RoweC, Rowe C, …
Journal ArticleDOI
Response to Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987
Eileen M. Moore,Alastair Mander,David Ames,Mark A. Kotowicz,Ross Carne,Henry Brodaty,Michael M Woodward,Kathryn A. Ellis,Ashley I. Bush,Noel G. Faux,David A. K. Watters +10 more
TL;DR: It is highlighted that B12 levels may be unrelated to the association of metformin with cognitive function and there is a need to test the issues raised more robustly—a point on which Goodarzi agrees.